These findings suggest that SV supplementation counters obesity‐induced muscle atrophy and metabolic dysfunction through flavonoid‐mediated AMPK activation, supporting its potential as a safe and effective nutritional strategy for managing sarcopenic obesity. Here, PRKAB1 is linked to obesity due to melanocortin 4 receptor deficiency.